Jason D. Fontenot
SVP, Chief Scientific Officer, SANGAMO THERAPEUTICS, INC.
Companies
- SANGAMO THERAPEUTICS, INCSVP, Chief Scientific Officer Mar 19, 2021 to Nov 28, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- SANGAMO THERAPEUTICS, INC SGMOQ136,270 shares2$15.0K at $0.11Nov 25, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 25, 2023Shares withheld for tax 1,030 shares at $0.38 of SANGAMO THERAPEUTICS, INC2
- Aug 25, 2023Shares withheld for tax 1,029 shares at $0.77 of SANGAMO THERAPEUTICS, INC3
- May 25, 2023Shares withheld for tax 1,029 shares at $1.33 of SANGAMO THERAPEUTICS, INC4
- Feb 25, 2023Shares withheld for tax 6,559 shares at $2.66 of SANGAMO THERAPEUTICS, INC5
- Feb 24, 2023Granted 42,750 shares of SANGAMO THERAPEUTICS, INC5
- Apr 25, 2022Shares withheld for tax 826 shares at $4.83 of SANGAMO THERAPEUTICS, INC6
- Feb 25, 2022Granted 45,100 shares of SANGAMO THERAPEUTICS, INC7
- Feb 25, 2022Shares withheld for tax 6,248 shares at $5.90 of SANGAMO THERAPEUTICS, INC7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Aug 29, 2023
- 4SEC EDGARForm 4 filed May 30, 2023
- 5SEC EDGARForm 4 filed Mar 6, 2023
- 6SEC EDGARForm 4 filed Apr 27, 2022
- 7SEC EDGARForm 4 filed Mar 1, 2022